DR. STEVEN NEIL FRANKEL O.D.
Prescription History 1114998317
Optometrist in Bridgeport, CT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. STEVEN NEIL FRANKEL O.D., an active Optometrist specialist practicing in Bridgeport, CT. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 318 documented patient claims. Among these therapy options, the most frequently utilized medication is Travoprost, which accounts for 89 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CT PrescribersVs. CT Avg |
|---|---|---|---|
| Travoprost | 89 | $138.47▼ below CT avg | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 89 Medicare prescriptions for Travoprost, about 2.5 times the volume of the typical Connecticut prescriber of this medication (36). Medicare paid an average of $138.47 per fill, versus $293.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 102.5 30-Day Fills standardized to 30-day supplies 2,785 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 49 | $10.06▼ below CT avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 49 Medicare prescriptions for Latanoprost, about a third of the volume of the typical Connecticut prescriber of this medication (125). Medicare paid an average of $10.06 per fill, versus $28.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 59.8 30-Day Fills standardized to 30-day supplies 1,630 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 49 | $282.90▼ below CT avg | ▲ More than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 49 Medicare prescriptions for Vyzulta, about 1.4 times the volume of the typical Connecticut prescriber of this medication (36). Medicare paid an average of $282.90 per fill, versus $504.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,340 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 32 | $369.17▼ below CT avg | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 32 Medicare prescriptions for Lumigan, about half the volume of the typical Connecticut prescriber of this medication (64). Medicare paid an average of $369.17 per fill, versus $553.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 41.5 30-Day Fills standardized to 30-day supplies 1,115 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 27 | $12.82▼ below CT avg | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 27 Medicare prescriptions for Timolol Maleate, about a third of the volume of the typical Connecticut prescriber of this medication (68). Medicare paid an average of $12.82 per fill, versus $40.91 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 56.1 30-Day Fills standardized to 30-day supplies 1,680 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 22 | $962.86▼ below CT avg | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 22 Medicare prescriptions for Xiidra, about 71% of the volume of the typical Connecticut prescriber of this medication (31). Medicare paid an average of $962.86 per fill, versus $1,168.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 28.5 30-Day Fills standardized to 30-day supplies 855 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 19 | $1,176.55▼ below CT avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 19 Medicare prescriptions for Restasis, about a third of the volume of the typical Connecticut prescriber of this medication (49). Medicare paid an average of $1,176.55 per fill, versus $1,318.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 16 | $221.86▼ below CT avg | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 16 Medicare prescriptions for Simbrinza, about half the volume of the typical Connecticut prescriber of this medication (35). Medicare paid an average of $221.86 per fill, versus $276.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 16 30-Day Fills standardized to 30-day supplies 438 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $32.83▼ below CT avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 15 Medicare prescriptions for Dorzolamide-Timolol, about 18% of the volume of the typical Connecticut prescriber of this medication (85). Medicare paid an average of $32.83 per fill, versus $40.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 24.4 30-Day Fills standardized to 30-day supplies 712 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. STEVEN NEIL FRANKEL O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Bridgeport, CT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CT prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
